SEED Innovations has just dropped its final results for the year ending March 2025, and there’s plenty to unpack. On the surface, we’ve got a 14% portfolio growth to £8.3 million and a robust £3.4 million cash war chest. But dig deeper, and the real story emerges: shares are trading at a jaw-dropping 74% discount to NAV, while Chairman Ian Burns prepares to exit stage left. Let’s slice through the RNS and see what this means for investors.
Portfolio Performance: Gains, Pains, and Strategic Plays
That 14% portfolio uplift didn’t happen by accident. SEED’s hybrid strategy—mixing long-term venture bets with tactical short-term trades—delivered despite what CEO Ed McDermott calls an “exceptionally challenging macroeconomic backdrop.” Here’s where the momentum came from:
Star Performers
- Avextra AG (Biotech/Cannabis): Up 13% to £3.1m. Why? Vertical integration from Portuguese cultivation to German production, plus new proprietary strain development.
- Clean Food Group (Biotech): Soared 45% to £1.7m. Their food-waste-to-oil tech scored a cosmetics deal with THG Labs and even landed a BBC feature.
- Inveniam (Fintech): Jumped 45% to £498k. Post-acquisition momentum and a strategic investment from UAE’s G42 boosted its AI-driven private markets platform.
Mixed Signals
- Juvenescence (Biotech): Slight dip to £2.5m due to FX, but masked huge progress—$76m Series B-1 raise with Abu Dhabi’s M42 and clinical breakthroughs in longevity therapeutics.
- Little Green Pharma (Cannabis): Down 16% to £443k on ASX price moves, but positioned to capitalise on Europe’s regulatory easing, especially in Germany and France.
Meanwhile, the short-term trading book generated tidy wins, like a 35% return on Pantheon Resources in just three months. Not life-changing money, but it proves SEED can pivot when liquidity dries up elsewhere.
Financial Health Check: The 74% Discount Elephant in the Room
Let’s address the glaring disconnect: a £11.8m NAV versus a market cap implied by a 1.6p share price. That 74% discount isn’t just steep—it’s cavernous. Yet the numbers tell a nuanced story:
- Cash Buffer: £3.4m in cash/receivables (29% of NAV) offers dry powder for deals or further buybacks.
- NAV Drag: The £11.8m NAV is down from £13.6m, but that’s largely due to the £2m special dividend and £0.2m buyback—not operational weakness.
- Cost Discipline: Operating expenses held flat at £744k despite inflation—a minor victory in this environment.
Burns didn’t mince words: this discount “significantly misrepresents the business.” Translation: either the market’s missing the plot, or SEED needs to force a rerating.
Strategic Crossroads: Buybacks, Dividends & The “What Next?”
Management’s sending clear signals with capital allocation:
- £2m Special Dividend: Rewarding patience while tacitly admitting deployment opportunities are scarce.
- Share Buybacks: Another £0.2m repurchased at fire-sale prices—logical when shares trade at 26p for every £1 of NAV.
The RNS hints at frustration: “If new investments aren’t made, we’ll look at other strategic options.” That’s boardroom code for “everything’s on the table”—potentially including a strategic review or even a winding-up vote if the discount persists.
Leadership Shuffle: Burns Out, Cairns In (For Now)
Ian Burns’ departure as Chair after this report lands feels symbolic. His farewell note stressed “realising SEED’s full potential,” implying unfinished business. Luke Cairns steps in as Interim Chair—a safe pair of hands, but his tenure feels like a holding pattern until either:
- Deployment accelerates, or
- The board pulls the lever on “strategic options.”
Worth noting: Burns remains a shareholder via Smoke Rise Holdings. He’s not cutting ties—just passing the baton.
Bottom Line: Discount as Catalyst?
SEED’s portfolio is ticking upward, but the discount is the story. For investors, this presents a binary bet:
- Bull Case: Cash + catalyst (new deals, liquidity events at Juvenescence/CFG) closes the gap. A 50% discount would still imply a 100%+ share price rally.
- Bear Case: The discount persists, forcing the board into radical action—asset sales, tender offers, or even a managed wind-down.
McDermott’s closing remarks ring true: “Prudent and opportunistic” sums up SEED’s stance. But patience wears thin at a 74% discount. One thing’s certain: the next 12 months will define whether this is a hidden gem or a permanent value trap.
